Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$78.8K
6.01K shares
What this filing means
SCHOENBERG MARK plans to sell 6.01K shares of UROGEN PHARMA LTD. valued at approximately $78.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2024ACC: 0001976408-24-000246
Officer· Chief Medical Officer
Since Jan 2019
6.01K
Shares to sell
$78.8K
Approx. market value
5K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
9/7/2023
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/7/2023 | Restricted Stock Units N/A | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.15K
Market value
$67.4K
6/10/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
859.00
Market value
$11.4K
9/9/2024
Total
Units
6.01K
Value
$78.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/10/2024 | 5.15K | $67.4K | — | Completed |
| Planned — Approximate Date | ||||
9/9/2024 | 859.00 | $11.4K | NASDAQ | Planned |
| Total | 6.01K | $78.8K | ||